ANCRE has a longstanding history of advancing research in the prevention, detection, and treatment of HPV-associated anal disease and anal cancer.
Under the pioneering leadership of Dr. Joel Palefsky, ANCRE has played an important role in advancing the understanding of anal HPV infection, anal high-grade squamous intraepithelial lesions (HSIL), and strategies to prevent anal cancer.
Today, ANCRE continues this work through clinical and translational research focused on anal cancer prevention, screening and early detection, diagnosis and treatment of anal HSIL, HPV-associated disease, and outcomes of care.
Our research brings together investigators, clinicians, research staff, and study participants with the goal of improving the prevention and care of anal cancer and translating research findings into clinical practice.
Contact us to participate in a study